vs
Side-by-side financial comparison of GRACO INC (GGG) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $593.2M, roughly 1.9× GRACO INC). GRACO INC runs the higher net margin — 22.3% vs -127.8%, a 150.1% gap on every dollar of revenue. On growth, GRACO INC posted the faster year-over-year revenue change (8.1% vs -2.5%). GRACO INC produced more free cash flow last quarter ($184.3M vs $148.6M). Over the past eight quarters, GRACO INC's revenue compounded faster (9.8% CAGR vs 1.3%).
Graco Inc. is an American industrial company that specializes in the development and manufacturing of fluid-handling systems and products. The company is headquartered in Minneapolis, Minnesota, and markets its products to customers worldwide.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
GGG vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $593.2M | $1.1B |
| Net Profit | $132.5M | $-1.4B |
| Gross Margin | 51.7% | 32.6% |
| Operating Margin | 26.7% | -116.0% |
| Net Margin | 22.3% | -127.8% |
| Revenue YoY | 8.1% | -2.5% |
| Net Profit YoY | 21.9% | -3093.9% |
| EPS (diluted) | $0.78 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $593.2M | $1.1B | ||
| Q3 25 | $543.4M | $1.0B | ||
| Q2 25 | $571.8M | $1.1B | ||
| Q1 25 | $528.3M | $1.0B | ||
| Q4 24 | $548.7M | $1.1B | ||
| Q3 24 | $519.2M | $1.1B | ||
| Q2 24 | $553.2M | $1.1B | ||
| Q1 24 | $492.2M | $1.1B |
| Q4 25 | $132.5M | $-1.4B | ||
| Q3 25 | $137.6M | $7.5M | ||
| Q2 25 | $127.6M | $-8.4M | ||
| Q1 25 | $124.1M | $-6.4M | ||
| Q4 24 | $108.7M | $-44.4M | ||
| Q3 24 | $122.2M | $-21.0M | ||
| Q2 24 | $133.0M | $-108.4M | ||
| Q1 24 | $122.2M | $2.0M |
| Q4 25 | 51.7% | 32.6% | ||
| Q3 25 | 53.2% | 36.1% | ||
| Q2 25 | 52.4% | 34.4% | ||
| Q1 25 | 52.6% | 37.6% | ||
| Q4 24 | 50.9% | 33.9% | ||
| Q3 24 | 53.2% | 37.2% | ||
| Q2 24 | 54.4% | 37.0% | ||
| Q1 24 | 54.1% | 33.1% |
| Q4 25 | 26.7% | -116.0% | ||
| Q3 25 | 30.3% | 7.0% | ||
| Q2 25 | 27.5% | 4.3% | ||
| Q1 25 | 27.3% | 4.5% | ||
| Q4 24 | 23.7% | 10.0% | ||
| Q3 24 | 28.1% | 7.4% | ||
| Q2 24 | 29.2% | -2.5% | ||
| Q1 24 | 27.0% | -5.1% |
| Q4 25 | 22.3% | -127.8% | ||
| Q3 25 | 25.3% | 0.7% | ||
| Q2 25 | 22.3% | -0.8% | ||
| Q1 25 | 23.5% | -0.6% | ||
| Q4 24 | 19.8% | -3.9% | ||
| Q3 24 | 23.5% | -1.9% | ||
| Q2 24 | 24.0% | -10.2% | ||
| Q1 24 | 24.8% | 0.2% |
| Q4 25 | $0.78 | $-10.23 | ||
| Q3 25 | $0.82 | $0.05 | ||
| Q2 25 | $0.76 | $-0.06 | ||
| Q1 25 | $0.72 | $-0.05 | ||
| Q4 24 | $0.63 | $-0.32 | ||
| Q3 24 | $0.71 | $-0.15 | ||
| Q2 24 | $0.77 | $-0.79 | ||
| Q1 24 | $0.71 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $624.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.9B |
| Total Assets | $3.3B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $624.1M | — | ||
| Q3 25 | $618.7M | $432.1M | ||
| Q2 25 | $534.9M | $454.2M | ||
| Q1 25 | $536.1M | $409.9M | ||
| Q4 24 | $675.3M | $558.8M | ||
| Q3 24 | $764.5M | $1.5B | ||
| Q2 24 | $666.0M | $542.8M | ||
| Q1 24 | $622.7M | $658.5M |
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.6B | $4.4B | ||
| Q2 25 | $2.5B | $4.5B | ||
| Q1 25 | $2.5B | $4.4B | ||
| Q4 24 | $2.6B | $4.3B | ||
| Q3 24 | $2.5B | $4.6B | ||
| Q2 24 | $2.4B | $4.5B | ||
| Q1 24 | $2.3B | $4.7B |
| Q4 25 | $3.3B | $8.5B | ||
| Q3 25 | $3.2B | $10.1B | ||
| Q2 25 | $3.0B | $10.1B | ||
| Q1 25 | $3.0B | $9.8B | ||
| Q4 24 | $3.1B | $9.6B | ||
| Q3 24 | $3.0B | $11.2B | ||
| Q2 24 | $2.9B | $10.4B | ||
| Q1 24 | $2.8B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $196.3M | $175.4M |
| Free Cash FlowOCF − Capex | $184.3M | $148.6M |
| FCF MarginFCF / Revenue | 31.1% | 13.4% |
| Capex IntensityCapex / Revenue | 2.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | $637.9M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $196.3M | $175.4M | ||
| Q3 25 | $179.2M | $51.7M | ||
| Q2 25 | $182.7M | $75.9M | ||
| Q1 25 | $125.4M | $-64.5M | ||
| Q4 24 | $185.2M | $312.6M | ||
| Q3 24 | $178.6M | $42.2M | ||
| Q2 24 | $139.0M | $9.5M | ||
| Q1 24 | $118.9M | $-1.4M |
| Q4 25 | $184.3M | $148.6M | ||
| Q3 25 | $175.7M | $29.8M | ||
| Q2 25 | $163.1M | $56.7M | ||
| Q1 25 | $114.8M | $-90.0M | ||
| Q4 24 | $171.3M | $274.9M | ||
| Q3 24 | $159.2M | $15.1M | ||
| Q2 24 | $102.7M | $-18.9M | ||
| Q1 24 | $81.7M | $-26.5M |
| Q4 25 | 31.1% | 13.4% | ||
| Q3 25 | 32.3% | 2.9% | ||
| Q2 25 | 28.5% | 5.4% | ||
| Q1 25 | 21.7% | -8.6% | ||
| Q4 24 | 31.2% | 24.2% | ||
| Q3 24 | 30.7% | 1.4% | ||
| Q2 24 | 18.6% | -1.8% | ||
| Q1 24 | 16.6% | -2.4% |
| Q4 25 | 2.0% | 2.4% | ||
| Q3 25 | 0.6% | 2.1% | ||
| Q2 25 | 3.4% | 1.8% | ||
| Q1 25 | 2.0% | 2.4% | ||
| Q4 24 | 2.5% | 3.3% | ||
| Q3 24 | 3.7% | 2.5% | ||
| Q2 24 | 6.6% | 2.7% | ||
| Q1 24 | 7.6% | 2.3% |
| Q4 25 | 1.48× | — | ||
| Q3 25 | 1.30× | 6.89× | ||
| Q2 25 | 1.43× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 0.97× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GGG
| Industrial | $284.3M | 48% |
| Contractor | $265.5M | 45% |
| Other | $43.4M | 7% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
